-
Noncompliance with treatment for latent tuberculosis can be monitored with the aid of a special urine test that checks for metabolites of isoniazid.
-
The FDA has approved aprepitant for preventing both acute and delayed nausea and vomiting associated with chemotherapy.
-
Influenza Vaccination and Reduction in Hospitalizations; Screening Men for Prostate and Colorectal Cancer; Weight Loss in CHF and Treatment with ACE-I
-
-
Despite the relatively frequent and probably increasing prevalence of recurrent bacterial skin infections, particularly furunculosis and cellulitis, there are few established evidence-based guidelines for their therapy and prevention. This review provides a pathophysiological approach to diagnosis, therapy, and prevention of these infections for the practicing physician and his or her patients.
-
Counterfeit Procrit Uncovered by FDA Surveillance; Pharmaceutical Marketing Campaigns in Full Swing; Ambulatory Antibiotic Reduction: Take the Good with the Bad; Nefazodone Under Attack Once Again; Lindane Receives Black Box Warning; Aspirin Could Help Reduce Colorectal Adenomas
-
-
-
Pneumococcal Vaccine Ineffective at CAP Prevention; Flu Vaccine Limits
Hospitalization; Verapamil Not Up To Competition; International
Companies Unite Against SARS; New FDA Comissioner Brings Controversy;
Janssen: Dear Doctor Letter for Risperidone
-
